Photo from wikipedia
Vonoprazan‐amoxicillin (VA) dual therapy has been shown to achieve acceptable cure rates for treatment of Helicobacter pylori(H. pylori) in Japan. Its effectiveness in other regions is unknown. We aimed to… Click to show full abstract
Vonoprazan‐amoxicillin (VA) dual therapy has been shown to achieve acceptable cure rates for treatment of Helicobacter pylori(H. pylori) in Japan. Its effectiveness in other regions is unknown. We aimed to explore the efficacy of VA dual therapy as first‐line treatment for H. pyloriinfection in China.
Keywords:
therapy;
dual therapy;
vonoprazan amoxicillin;
amoxicillin dual;
pyloriinfection china
Journal Title: Helicobacter
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Helicobacter
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!